Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,055 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
PA-824 , moxifloxacin and pyrazinamide combination therapy for tuberculosis.
Dawson R, Diacon A. Dawson R, et al. Expert Opin Investig Drugs. 2013 Jul;22(7):927-32. doi: 10.1517/13543784.2013.801958. Epub 2013 May 21. Expert Opin Investig Drugs. 2013. PMID: 23687915 Review.
Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis.
Dawson R, Narunsky K, Carman D, Gupte N, Whitelaw A, Efron A, Barnes GL, Hoffman J, Chaisson RE, McIlleron H, Dorman SE. Dawson R, et al. Int J Tuberc Lung Dis. 2015 Jul;19(7):780-6. doi: 10.5588/ijtld.14.0868. Int J Tuberc Lung Dis. 2015. PMID: 26056101 Free PMC article. Clinical Trial.
Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents.
Diacon AH, Maritz JS, Venter A, van Helden PD, Dawson R, Donald PR. Diacon AH, et al. Among authors: dawson r. Clin Microbiol Infect. 2012 Jul;18(7):711-7. doi: 10.1111/j.1469-0691.2011.03626.x. Epub 2011 Aug 18. Clin Microbiol Infect. 2012. PMID: 21851489
Treatment group means rank correlation coefficients were r=0.472, r=0.910 and r=0.818, respectively, for EBA 0-2 days, EBA 0-7 days and EBA 0-14 days. ...
Treatment group means rank correlation coefficients were r=0.472, r=0.910 and r=0.818, respectively, for EBA 0-2 days, …
Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients.
Diacon AH, Dawson R, Hanekom M, Narunsky K, Venter A, Hittel N, Geiter LJ, Wells CD, Paccaly AJ, Donald PR. Diacon AH, et al. Among authors: dawson r. Int J Tuberc Lung Dis. 2011 Jul;15(7):949-54. doi: 10.5588/ijtld.10.0616. Int J Tuberc Lung Dis. 2011. PMID: 21682970 Clinical Trial.
Utility of quantitative T-cell responses versus unstimulated interferon-{gamma} for the diagnosis of pleural tuberculosis.
Dheda K, van Zyl-Smit RN, Sechi LA, Badri M, Meldau R, Meldau S, Symons G, Semple PL, Maredza A, Dawson R, Wainwright H, Whitelaw A, Vallie Y, Raubenheimer P, Bateman ED, Zumla A. Dheda K, et al. Among authors: dawson r. Eur Respir J. 2009 Nov;34(5):1118-26. doi: 10.1183/09031936.00005309. Epub 2009 Apr 22. Eur Respir J. 2009. PMID: 19386693
(R)TB, QuantiFERON(R)-TB Gold In-tube), purified protein derivative (PPD) and heparin-binding haemagglutinin (HBHA)) in 78 South African TB suspects. ...(R)TB: 86, 60, 84 and 64%, respectively; QuantiFERON(R)-TB Gold In-tube: 57, 80, 87 and 44%, respec …
(R)TB, QuantiFERON(R)-TB Gold In-tube), purified protein derivative (PPD) and heparin-binding haemagglutinin (HBHA)) in 78 Sou …
Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis.
Dheda K, van Zyl-Smit RN, Meldau R, Meldau S, Symons G, Khalfey H, Govender N, Rosu V, Sechi LA, Maredza A, Semple P, Whitelaw A, Wainwright H, Badri M, Dawson R, Bateman ED, Zumla A. Dheda K, et al. Among authors: dawson r. Thorax. 2009 Oct;64(10):847-53. doi: 10.1136/thx.2009.116376. Epub 2009 Jul 9. Thorax. 2009. PMID: 19592392
Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis.
Murthy SE, Chatterjee F, Crook A, Dawson R, Mendel C, Murphy ME, Murray SR, Nunn AJ, Phillips PPJ, Singh KP, McHugh TD, Gillespie SH; REMoxTB Consortium. Murthy SE, et al. Among authors: dawson r. BMC Med. 2018 May 21;16(1):73. doi: 10.1186/s12916-018-1053-3. BMC Med. 2018. PMID: 29779492 Free PMC article.
Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial.
Calligaro GL, Theron G, Khalfey H, Peter J, Meldau R, Matinyenya B, Davids M, Smith L, Pooran A, Lesosky M, Esmail A, Miller MG, Piercy J, Michell L, Dawson R, Raine RI, Joubert I, Dheda K. Calligaro GL, et al. Among authors: dawson r. Lancet Respir Med. 2015 Aug;3(8):621-30. doi: 10.1016/S2213-2600(15)00198-8. Epub 2015 Jul 22. Lancet Respir Med. 2015. PMID: 26208996 Clinical Trial.
Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis.
Wallis RS, Dawson R, Friedrich SO, Venter A, Paige D, Zhu T, Silvia A, Gobey J, Ellery C, Zhang Y, Eisenach K, Miller P, Diacon AH. Wallis RS, et al. Among authors: dawson r. PLoS One. 2014 Apr 14;9(4):e94462. doi: 10.1371/journal.pone.0094462. eCollection 2014. PLoS One. 2014. PMID: 24732289 Free PMC article. Clinical Trial.
Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study.
Bryant JM, Harris SR, Parkhill J, Dawson R, Diacon AH, van Helden P, Pym A, Mahayiddin AA, Chuchottaworn C, Sanne IM, Louw C, Boeree MJ, Hoelscher M, McHugh TD, Bateson AL, Hunt RD, Mwaigwisya S, Wright L, Gillespie SH, Bentley SD. Bryant JM, et al. Among authors: dawson r. Lancet Respir Med. 2013 Dec;1(10):786-92. doi: 10.1016/S2213-2600(13)70231-5. Epub 2013 Nov 21. Lancet Respir Med. 2013. PMID: 24461758 Free PMC article. Clinical Trial.
1,055 results
Jump to page
Feedback